According to a study published in JAMA, nearly 40% of GLP-1 prescriptions for diabetes are now being used off-label for weight loss or other unapproved conditions
What Side Effects Have Been Reported
While traditional non-liposomal vitamin C had to go through enzymatic degradation, oxidation, and poor mucosal transport, which results in its sharp spike and quick fall in plasma levels, Phospholipid encapsulation, on the other hand, provides a sustained release, improved mucosal uptake, and higher vitamin C plasma concentration [3]
The nasal spray format provides a convenient, non-invasive delivery method, offering enhanced absorption and ease of use for consistent daily support
More than 10,000 patients with diabetes were given semaglutide and compared to controls, which included placebo, SGLT-2 inhibitors, and other GLP-1 agonists in the case of liraglutide